Context
The role of androgen excess as a contributing factor to abnormal glucose metabolism (AGM) and insulin resistance in women remains controversial.
Objective
To investigate whether hyperandrogenemia (HA) estimated by serum testosterone (T) level and free androgen index (FAI) at ages 31 and 46 is associated with insulin resistance, insulin secretion and AGM by age 46.
Design
Prospective study including 5,889 females followed at ages 31 and 46.
Setting
General community.
Participants
Women with HA were compared with normoandrogenic women at ages 31 and 46.
Intervention
None.
Main outcome measurements
AGM, including pre-diabetes and T2DM, homeostatic model assessments of insulin resistance (HOMA–IR) and of pancreatic β-cell function (HOMA–B).
Results
At age 31, HA women displayed increased HOMA–IR P=0.05), HOMA–B (P=0.006), and higher fasting insulin (P=0.034) than normoandrogenic women after adjusting for body mass index (BMI). At age 46, there was a nonsignificant trend towards higher fasting glucose (P=0.07) and glycated hemoglobin A1 (P=0.067) levels in HA women. Women in the highest T quartile (odds ratio [OR]= 1.80;95%CI, 1.15–2.82) at age 31 and in the two highest FAI quartiles at ages 31 (Q4:OR=3.76;95%CI, 2.24–6.32) and 46 (Q4:OR=2.79;95%CI, 1.74–4.46) had increased risk for AGM, independently of BMI, when compared with women in Q1. Sex hormone-binding globulin (SHBG) was inversely associated with AGM (at age 31:Q4:OR=0.37;95%CI, 0.23–0.60, at age 46:Q4:OR=0.28;95%CI, 0.17–0.44).
Conclusion
Hyperandrogenemia and low SHBG in early and middle age associates with AGM independently of BMI.